Maze Therapeutics, Inc.
MAZE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,087 | -$33,679 | -$32,786 | -$29,579 |
| Dep. & Amort. | $571 | $649 | $684 | $705 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,864 | $3,237 | $3,226 | $2,851 |
| Change in WC | $2,463 | -$1,038 | -$1,425 | $1,031 |
| Other Non-Cash | -$1,453 | $779 | $785 | $2,540 |
| Operating Cash Flow | -$24,642 | -$30,052 | -$29,516 | -$22,452 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$68 | -$393 | -$299 | -$605 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$66,815 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$66,883 | -$393 | -$299 | -$605 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$16,176 |
| Stock Issued | -$128,364 | $612 | $127,752 | $70,262 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $272,121 | $0 | -$374 | $16,176 |
| Financing Cash Flow | $143,757 | $612 | $127,378 | $70,262 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52,232 | -$29,833 | $97,563 | $47,205 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $265,630 | $295,463 | $197,900 | $150,695 |
| End Cash | $317,862 | $265,630 | $295,463 | $197,900 |
| Free Cash Flow | -$24,710 | -$30,445 | -$29,815 | -$23,057 |